Genome-wide association studies (GWAS) have identified that chromosome 15q25.1, composed of nicotinic acetylcholine receptor genes, including CHRNA5 and CHRNA3, are lung cancer susceptibility regions [5], [6] and play a potential role in multiple smoking-related phenotypes and nicotine dependence [7]. This evidence concerns the gene CHRNA3 and lung carcinoma.